Thus, our novel findings in established T2D extend our previous observations in patients at risk of developing T2D that the systemic presence of IL-21R+ CD4 T cells is reduced in obesity, pre-diabetes and T2D. This evidence concerns the gene CD4 and diabetes mellitus.